Major pharma deal accelerates development of a next-generation experimental therapy — signaling strong confidence in new targeted treatments for breast cancer.
🔗
https://www.statnews.com/2026/03/20/novartis-acquires-synnovation-breast-cancer-drug-snv4818/
#HealthNews 🌿
STATNovartis picks up experimental breast cancer drug for $2B
Looking to bolster its pipeline, Novartis is buying a breast cancer drug candidate for $2 billion from Delaware-based Synnovation Therapeutics.
